At a Glance
| Feature | Detail |
|---|---|
| Name / structure | SNAP-8, acetyl octapeptide-3: Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2; Argireline (acetyl hexapeptide-8) extended by two amino acids |
| Origin | Lipotec (Barcelona), now distributed by Lubrizol |
| Mechanism | Mimics the N-terminus of SNAP-25 and is proposed to destabilise the SNARE complex, reducing acetylcholine release at the nerve endings of expression muscles |
| Used for | Expression lines (forehead, crow’s feet) in cosmetic creams, serums and microneedle patches |
| Route | Topical; microneedle patches |
| Typical dose range | Manufacturer: 3–10 % of SNAP-8 solution (0.05 % peptide), about 0.0015–0.005 % pure peptide in the product |
| Evidence level | Limited: manufacturer data and two industry-run studies of multi-ingredient microneedle patches; somewhat better data for the parent peptide Argireline |
| Regulatory status | Cosmetic ingredient (EU and US); not a drug; WADA: topical cosmetic use not targeted |
SNAP-8 belongs to a small family of cosmetic peptides with a clever pitch: copy a piece of the nerve’s own release machinery, put it in a cream, and get a little of what botulinum toxin does without the needle. It is one of the few peptides in this library that many people already own without knowing it, because it appears in mainstream eye creams and serums.
My verdict: SNAP-8 is a reasonable cosmetic ingredient with a weak evidence base. Expect subtle softening of fine expression lines at best, not a Botox substitute. The interesting question is less whether the mechanism works in a dish and more whether enough of it gets through the skin.
How it works
To contract a muscle, a nerve ending releases acetylcholine from vesicles. Release needs the SNARE complex, a bundle of three proteins (SNAP-25, syntaxin and synaptobrevin) that zips the vesicle onto the membrane. Botulinum toxin type A cuts SNAP-25 and stops release.
Argireline (Ac-EEMQRR-NH2) was designed from the N-terminal end of SNAP-25. In laboratory studies it interfered with SNARE complex formation and inhibited neurotransmitter release with a potency comparable to botulinum toxin A, though with much lower efficacy [1]. SNAP-8 adds two amino acids to this sequence with the aim of a tighter fit and a stronger effect. The mechanism is plausible. Delivery is the weak point: in human and animal skin, nearly all of a 10 % Argireline cream stayed on the surface or in the outer horny layer, about 0.01 % of the applied dose reached the epidermis, and none was detected in the dermis [5]. Expression muscles lie below the dermis.
What the evidence shows
SNAP-8 (acetyl octapeptide-3)
| Study | Design | n | Product | Finding |
|---|---|---|---|---|
| Manufacturer data [8] | Unpublished in-vivo test | 17 women | Cream with 10 % SNAP-8 solution, twice daily for 28 days | Reported “up to” 63 % reduction in maximum wrinkle depth, a best-case figure |
| Avcil 2020 [4] | Single-centre, 12 weeks, no placebo arm | Healthy adults with aged skin | Hyaluronic acid microneedle patch with acetyl octapeptide-3, palmitoyl tripeptide-5, arginine/lysine polypeptide, adenosine and seaweed extracts | Fine lines and wrinkles −25.8 %; hydration +15.4 %; dermal density +14.2 %; no skin reactions |
| Shin 2024 [3] | Split-face, placebo-patch controlled, 28 days | 24 | Microneedle patch with acetyl octapeptide-3, ascorbyl glucoside and cyclic lysophosphatidic acid vs hyaluronic acid-only patch | Better eye-wrinkle scores, elasticity and lower water loss on the active side; no adverse effects |
Both published studies tested multi-ingredient microneedle patches from the same patch manufacturer, so the effect of SNAP-8 itself cannot be isolated.
Argireline (the parent peptide)
The original Argireline paper reported up to 30 % reduction in wrinkle depth after 30 days of a 10 % emulsion in healthy women [1]. A multicentre study in 60 Chinese adults, randomised 3:1 to Argireline or placebo applied twice daily to periorbital lines for 4 weeks, reported an overall anti-wrinkle efficacy of 48.9 % and a significant reduction in wrinkle depth [2]. A 2025 review concluded that the peptide’s hydrophilic nature and size limit skin permeability and that its ability to reach neuromuscular junctions remains uncertain [7].
Dosing
For informational purposes only — this summarises doses used in research and practice; it is not a prescription or individual medical advice.
| Goal | Dose | Route | Frequency / timing | Cycle length | Basis |
|---|---|---|---|---|---|
| Expression lines, finished cosmetic | 3–10 % of SNAP-8 solution (≈0.0015–0.005 % pure peptide) | Topical cream or serum | Twice daily | At least 4 weeks, then ongoing | Label (manufacturer use level) [8] |
| Manufacturer efficacy test | 10 % SNAP-8 solution | Topical | Twice daily | 28 days | Manufacturer data [8] |
| Argireline comparison | 10 % Argireline emulsion | Topical | Twice daily | 4 weeks | Trial [1][2] |
| Enhanced delivery | Acetyl octapeptide-3 in dissolving microneedle patches | Microneedle patch | Overnight or as directed | 4–12 weeks | Trial [3][4] (multi-ingredient) |
| DIY serums from reconstituted vials | Concentrations not standardised | Topical | Daily | Weeks to months | Anecdotal (r/45PlusSkincare) |
| Injection into wrinkles | No dose reported | Intradermal | Not established | Not established | Anecdotal, no human data (r/USPeptides) |
A frequent mix-up: “10 % SNAP-8” on a label usually means 10 % of the supplied solution, not 10 % pure peptide. DIY users who dissolve research-grade powder can end up with concentrations hundreds of times above what the manufacturer tested, with unknown irritation risk. For comparison, the US Cosmetic Ingredient Review panel judged the parent peptide safe up to 0.005 % in cosmetics and found the data insufficient above that [6].
What people report: what works and what doesn’t
Reported to work
- Subtle softening of fine expression lines, more often visible in comparison photos than in the mirror, after about 4 to 8 weeks (researchsafe forum).
- Better skin feel and hydration, which some users value more than any change in wrinkles (r/SkincareAddiction).
Mixed or unclear
- Enthusiasts making DIY serums from research vials describe it as a Botox replacement; most other users describe a far smaller effect (r/45PlusSkincare).
Reported not to work, or disappointing
- No visible change after a month, sometimes with small breakouts (r/USPeptides).
- Sceptical threads argue that “Botox in a bottle” is overstated (r/peptidebenchmark), and some Argireline users felt their lines looked worse in the first weeks (r/SkincareAddiction).
What a proper trial would need to show: a placebo-controlled, independently run study of a single-ingredient SNAP-8 product with blinded wrinkle measurement over 12 weeks, paired with a skin penetration study at the same concentration.
Safety and side effects
Topical SNAP-8 was well tolerated in the manufacturer and industry studies [3][4]. Possible effects are those of any cosmetic: irritation, redness and contact allergy to the formulation. Because penetration is minimal, systemic effects are not expected from cosmetic use.
Unknowns: DIY concentrations far above the tested range, use on broken skin or right after aggressive microneedling (more peptide reaches deeper layers), and injection, for which there are no safety data at all. Injecting a cosmetic powder into the face adds infection, granuloma and contamination risks without evidence of benefit.
Legal and regulatory status
- United States. A cosmetic ingredient. Products may claim to improve the appearance of lines; a claim to relax muscles or treat a condition would make the product a drug. It is not on FDA compounding lists.
- EU and Germany. Permitted as a cosmetic ingredient under the EU Cosmetics Regulation. It is not a medicine.
- Sport. Topical cosmetic use is not targeted by WADA.
How it fits
| SNAP-8 | Argireline | Botulinum toxin A | GHK-Cu (topical) | |
|---|---|---|---|---|
| Target | SNARE complex (weak) | SNARE complex (weak) | Cleaves SNAP-25 | Collagen and matrix remodelling |
| Evidence | Manufacturer data, combination patches | Small trials | Many large RCTs, approved | Controlled topical studies |
| Effect size | Subtle | Subtle | Strong, 3–4 months | Gradual change in skin quality |
SNAP-8 targets expression lines; copper peptides such as GHK-Cu and AHK-Cu target skin and hair structure. Sun protection and retinoids remain the best-supported topical anti-ageing measures; peptides are optional extras.
Related Articles
- GHK-Cu for Skin: Anti-Aging Evidence and Protocols
- AHK-Cu: The Hair Copper Peptide With One Lab Study
- Collagen Peptides: Types, Benefits and Evidence
- Peptide Safety Overview
Frequently asked questions
What is SNAP-8?
SNAP-8 is the trade name of acetyl octapeptide-3, an eight-amino-acid cosmetic peptide developed by Lipotec as an elongated version of Argireline (acetyl hexapeptide-8). It mimics the N-terminal end of SNAP-25, a protein nerves need to release acetylcholine.
Does SNAP-8 work like Botox?
Only in concept. Botulinum toxin cleaves SNAP-25 inside the nerve ending and blocks muscle contraction for months. SNAP-8 is meant to compete weakly with SNAP-25 in the release machinery. Studies on its parent peptide show that very little crosses the skin barrier, and the reported effects are modest and mostly from manufacturer or industry studies.
What concentration of SNAP-8 is effective?
The manufacturer recommends 3–10% of the SNAP-8 solution in a finished product. That solution contains 0.05% peptide, so the finished product contains roughly 0.0015–0.005% pure peptide. The manufacturer's in-vivo test used 10% of the solution twice daily for 28 days.
Can you inject SNAP-8?
Some people report injecting it into wrinkles. There is no published human safety or efficacy data for injected SNAP-8, and it is not made or tested as an injectable.
References
- Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002. PMID: 18498523. https://pubmed.ncbi.nlm.nih.gov/18498523/
- Wang Y, Wang M, Xiao XS, et al. The anti wrinkle efficacy of synthetic hexapeptide (Argireline) in Chinese Subjects. J Cosmet Laser Ther. 2013. PMID: 23607739. https://pubmed.ncbi.nlm.nih.gov/23607739/
- Shin JY, Han D, Yoon KY, et al. Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities. Ann Dermatol. 2024. PMID: 39082657. https://pubmed.ncbi.nlm.nih.gov/39082657/
- Avcil M, Akman G, Klokkers J, et al. Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study. J Cosmet Dermatol. 2020. PMID: 31134751. https://pubmed.ncbi.nlm.nih.gov/31134751/
- Kraeling ME, Zhou W, Wang P, et al. In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutan Ocul Toxicol. 2015. PMID: 24754410. https://pubmed.ncbi.nlm.nih.gov/24754410/
- Johnson W Jr, Bergfeld WF, Belsito DV, et al. Safety Assessment of Acetyl Hexapeptide-8 Amide as Used in Cosmetics. Int J Toxicol. 2025. PMID: 40673537. https://pubmed.ncbi.nlm.nih.gov/40673537/
- Zdrada-Nowak J, Surgiel-Gemza A, Szatkowska M. Acetyl Hexapeptide-8 in Cosmeceuticals: A Review of Skin Permeability and Efficacy. Int J Mol Sci. 2025. PMID: 40565185. https://pubmed.ncbi.nlm.nih.gov/40565185/
- Lipotec. SNAP-8 peptide solution: product information (manufacturer datasheet, archived by COSSMA). https://www.cossma.com/fileadmin/all/cossma/Archiv/ProductInfo/COS1005_14_ProdSnap8.pdf
Disclaimer: This article is for information and education only and is not medical advice. SNAP-8 is a cosmetic ingredient, not a medicine.
